-Fast Track Designation was granted for BB-301 following U.S. Food and Drug Administration ( FDA ) review of positive interim clinical study results and proprietary Responder Analysis planned for use in pivotal study for ...

BNTC

<p>-Fast Track 认证已授予 BB-301，此前美国食品药品监督管理局（FDA）对积极的中期临床研究结果进行了审查，并计划在关键研究中使用专有的响应者分析</p>

Benitec Biopharma 发布 2026 年第一季度财务业绩并提供运营情况更新